Inside Nephrology: A Weekly Review
Nefrologia
Bladder Cancer Surgery and Kidney Disease Therapies
This week we discuss practice-changing studies on bladder cancer surgery techniques, new therapies for kidney disease, and the economic impact of CKD progression. Featuring research from NEJM, JAMA, and JASN.
Bibliography
1. Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer.
Authors: Lerner SP, Tangen C, Svatek RS, et al.
Journal: The New England journal of medicine, 2024 Oct 3
PMID: 39589370
DOI: 10.1056/NEJMoa2401497
2. Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial.
Authors: Neuen BL, Perkovic V, Agarwal R, et al.
Journal: JAMA, 2026 Jul 21
PMID: 42246414
DOI: 10.1001/jama.2026.9923
3. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
Authors: Brock PR, Maibach R, Childs M, et al.
Journal: The New England journal of medicine, 2018 Jun 21
PMID: 29924955
DOI: 10.1056/NEJMoa1801109
4. Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer.
Authors: Lerner SP, Tangen C, Svatek RS, et al.
Journal: The New England journal of medicine, 2024 Oct 3
PMID: 39589370
DOI: 10.1056/NEJMoa2401497
5. Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Authors: Pascual J, Berger SP, Witzke O, et al.
Journal: Journal of the American Society of Nephrology : JASN, 2018 Jul
PMID: 29752413
DOI: 10.1681/ASN.2018010009
6. Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Authors: Pascual J, Berger SP, Witzke O, et al.
Journal: Journal of the American Society of Nephrology : JASN, 2018 Jul
PMID: 29752413
DOI: 10.1681/ASN.2018010009
7. Subcutaneous versus intravenous nivolumab for renal cell carcinoma.
Authors: Albiges L, Bourlon MT, Chacón M, et al.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology, 2025 Jan
PMID: 39288844
DOI: 10.1016/j.annonc.2024.09.002
8. Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer.
Authors: Lerner SP, Tangen C, Svatek RS, et al.
Journal: The New England journal of medicine, 2024 Oct 3
PMID: 39589370
DOI: 10.1056/NEJMoa2401497
9. Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme.
Authors: Jha V, Al-Ghamdi SMG, Li G, et al.
Journal: Advances in therapy, 2023 Oct
PMID: 37493856
DOI: 10.1007/s12325-023-02608-9
Authors: Lerner SP, Tangen C, Svatek RS, et al.
Journal: The New England journal of medicine, 2024 Oct 3
PMID: 39589370
DOI: 10.1056/NEJMoa2401497
2. Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial.
Authors: Neuen BL, Perkovic V, Agarwal R, et al.
Journal: JAMA, 2026 Jul 21
PMID: 42246414
DOI: 10.1001/jama.2026.9923
3. Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
Authors: Brock PR, Maibach R, Childs M, et al.
Journal: The New England journal of medicine, 2018 Jun 21
PMID: 29924955
DOI: 10.1056/NEJMoa1801109
4. Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer.
Authors: Lerner SP, Tangen C, Svatek RS, et al.
Journal: The New England journal of medicine, 2024 Oct 3
PMID: 39589370
DOI: 10.1056/NEJMoa2401497
5. Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Authors: Pascual J, Berger SP, Witzke O, et al.
Journal: Journal of the American Society of Nephrology : JASN, 2018 Jul
PMID: 29752413
DOI: 10.1681/ASN.2018010009
6. Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Authors: Pascual J, Berger SP, Witzke O, et al.
Journal: Journal of the American Society of Nephrology : JASN, 2018 Jul
PMID: 29752413
DOI: 10.1681/ASN.2018010009
7. Subcutaneous versus intravenous nivolumab for renal cell carcinoma.
Authors: Albiges L, Bourlon MT, Chacón M, et al.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology, 2025 Jan
PMID: 39288844
DOI: 10.1016/j.annonc.2024.09.002
8. Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer.
Authors: Lerner SP, Tangen C, Svatek RS, et al.
Journal: The New England journal of medicine, 2024 Oct 3
PMID: 39589370
DOI: 10.1056/NEJMoa2401497
9. Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme.
Authors: Jha V, Al-Ghamdi SMG, Li G, et al.
Journal: Advances in therapy, 2023 Oct
PMID: 37493856
DOI: 10.1007/s12325-023-02608-9
